Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| ABBV | AbbVie, Inc. | -0.96% | 92.13 | 1.9% | $1192.97m | |
| JNJ | Johnson & Johnson | -0.87% | 144.44 | 0.7% | $1057.09m | |
| BMY | Bristol-Myers Squibb Co. | -0.57% | 60.79 | 1.0% | $967.46m | |
| PFE | Pfizer Inc. | 0.64% | 37.50 | 0.9% | $831.88m | |
| MRK | Merck & Co., Inc. | -0.22% | 76.38 | 0.7% | $796.50m | |
| LLY | Eli Lilly & Co. | -0.69% | 151.23 | 1.1% | $417.06m | |
| AZN | AstraZeneca Plc | -0.11% | 55.22 | 1.2% | $261.94m | |
| NVS | Novartis AG | -0.09% | 84.91 | 0.2% | $156.50m | |
| GSK | GlaxoSmithKline Plc | -0.37% | 40.88 | 0.2% | $140.53m | |
| NVO | Novo Nordisk A/S | 0.05% | 64.85 | 0.1% | $87.00m | |
| SNY | Sanofi | -0.30% | 47.30 | 0.2% | $78.78m | |
| RGEN | Repligen Corp. | -0.57% | 139.51 | 7.1% | $73.05m | |
| ARCT | Arcturus Therapeutics Holdings, Inc. | 7.71% | 58.27 | 0.0% | $60.48m | |
| BHVN | Biohaven Pharmaceutical Holding Co. Ltd. | 11.80% | 58.37 | 0.0% | $42.40m | |
| RETA | Reata Pharmaceuticals, Inc. | 1.04% | 160.00 | 3.4% | $38.83m |
Company Profile
Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products. Its product candidates are bardoxolone methyl and omaveloxolone, which activate the transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation. The company was founded by W. Christian Wigley, Waldemar Priebe, Philip J. Thomas, Jef Karel de Brabander, Thomas C. Südhof, Jonathan M. Graff and J. Warren Huff on September 1, 2002 and is headquartered in Irving, TX.